Clinical Trials Directory

Trials / Completed

CompletedNCT03671187

Pulmonary Rehabilitation and Smoking

Effectiveness of Pulmonary Rehabilitation in Smoker Patients With COPD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Izmir Katip Celebi University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients.

Detailed description

Pulmonary rehabilitation (PR) is known to reduce dyspnea, increase exercise capacity, reduce psychological symptoms and improve quality of life in COPD patients. Some patients continue to smoke despite their illness. Smoking does not create a contraindication to PR. There is insufficient evidence on the effectiveness of PR programs in smoking COPD patients. The purpose of this study, PR completed the program to determine the effectiveness of PR smoker COPD patients. People who have completed the PR program, smoking and not smoking will be included into the study. Data of carbon monoxide diffusion test, body plethysmography, 6-min walk test, blood gas analysis, mMRC dyspnea scale, hospital anxiety depression scale, SGRQ and SF-36 quality of life questionnaire performed before and after the program will be analyzed.

Conditions

Interventions

TypeNameDescription
OTHERExercise8 week exercise program

Timeline

Start date
2015-01-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2018-09-14
Last updated
2018-09-17

Source: ClinicalTrials.gov record NCT03671187. Inclusion in this directory is not an endorsement.